FDA Inspection
Aurobindo Pharma LimitedFDA Inspection 1169446 - Aurobindo Pharma Limited - May 10, 2022
Discuss this record with AI
Record Details
This FDA Inspection record concerns Aurobindo Pharma Limited, with an inspection on May 10, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
Open in Dashboard
ID · b9201ac7-5ec4-46dd-8aaf-7304c3c93094
Violation Codes6
21 CFR 211.100(a)21 CFR 211.166(a)21 CFR 211.18821 CFR 211.19221 CFR 211.6321 CFR 211.68(b)
Full citation text and observation details available on the Dashboard.